Investigations into Ro-specific antibody-associated congenital cardiac conduction defects

Clin Investig. 1992 Jun;70(6):492-6. doi: 10.1007/BF00210230.

Abstract

Forty-two babies with different congenital cardiac conduction defects, and in 12 cases the mothers, were tested for autoantibodies to Ro, La, U1RNP and Sm. Ro-specific antibodies were detected most frequently. They were to be found in 16 sera from infants and in 8 maternal serum samples. The occurrence of anti-Ro was associated preferentially with several atrioventricular conduction blocks. The sex relation of anti-Ro associated congenital heart block did not show a typical preference (6 male/10 female). At the time of giving birth, 5 anti-Ro-positive mothers did not have any clinical symptoms of rheumatic autoimmune diseases. Three of them had a first degree atrioventricular block. Our findings indicate that all pregnant women at risk for anti-Ro like connective tissue disease or cardiac conduction defects should be tested for these autoantibodies because of the suspicion of cardiac conduction abnormalities in the offspring. Anti-Ro-positive infants should be examined for structural heart disease by echocardiography.

MeSH terms

  • Antibodies, Antinuclear / isolation & purification*
  • Autoantibodies / isolation & purification
  • Echocardiography
  • Female
  • Heart Block / immunology
  • Heart Conduction System / abnormalities*
  • Heart Defects, Congenital / diagnostic imaging
  • Heart Defects, Congenital / immunology*
  • Humans
  • Infant
  • Infant, Newborn
  • Male
  • Pregnancy
  • Pregnancy Complications, Cardiovascular / immunology
  • Risk Factors

Substances

  • Antibodies, Antinuclear
  • Autoantibodies
  • SS-A antibodies